{
    "doi": "https://doi.org/10.1182/blood-2021-154330",
    "article_title": "Frequency and Survival of T-Cell Lymphomas in Peru: Initial Report of a Peruvian Registry Experience ",
    "article_date": "November 5, 2021",
    "session_type": "624.Hodgkin Lymphomas and T/NK cell Lymphomas: Clinical and Epidemiological",
    "abstract_text": "Introduction : T-cell lymphomas are a relatively rare and heterogeneous group of lymphoid neoplasms. Its incidence relies on viral infections incidence as Human T-cell lymphotropic virus type I-II (HTLV-I/II) and Ebstein Bar virus (EBV). Specifically, these viruses have a significantly higher incidence in Latin-American populations. Our objective was to calculate the incidence and survival of T-cell lymphomas in the largest Peruvian population based on a national registry. Methods : We conducted a multicenter, retrospective registry study of non-Hodgkin T cell lymphoma. The data was extracted from Instituto Nacional de Enfermedades Neoplasicas and Oncosalud-AUNA, Lima-Peru, from January 2010 to December 2019, a total of 948 patients who were diagnosed as mature T cell non-Hodgkin lymphoma based on the World Health Organization Classification 2008 were enrolled. T-lymphoblastic lymphoma/leukemia was excluded. Overall survival was calculated based on death dates from the Peruvian national identification registry (RENIEC). Results : The median age was 51 years (range, 1-94), and male and female patients were 512 (54%) and 436 (46%). Among the 948 patients enrolled, Peripheral T-cell lymphoma was the common neoplasm accounting for 23% (n=221), and Extra-Nodal NK T-lymphoma (22%, n=213), Adult T-cell lymphoma (22%, n=205), Anaplasic Large cell lymphoma (14%, n=131), Cutaneous T-cell lymphoma (14%, n=129) (Figure 1a) . At the time of diagnosis, extranodal disease was found in 68.6% (650) of patients. By July 2021, only 15.3% of cases were in remission and 37% (350) were alive. Median global overall survival of T-cell lymphomas was 1 year (0.8-1.1), Cutaneous T-cell lymphoma had the highest survival and Adult T-cell lymphoma had the lowest survival (Table 1 and Figure 1b) . Conclusion : This initial report shows a relatively high frequency of mature T-cell lymphomas in Latin-America real-world setting, and confirms that T-cell lymphomas patients had a dismal outcome. The clinical outcome for patients with T-cell lymphomas subtypes is poor with standard therapies, and novel agents and new modalities are needed to improve survival. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Disclosures No relevant conflicts of interest to declare.",
    "author_names": [
        "Daniel J Enriquez",
        "Jhoisy Casas",
        "Gustavo Sandival",
        "Johan Espino",
        "Evelyn Espinoza-Morales",
        "Elizabeth Cervantes",
        "Melanie Castro-Mollo",
        "F\u00e1tima Jim\u00e9nez-Mozo",
        "Daniela Due\u00f1as",
        "Carlos Barrionuevo",
        "Juan C Haro",
        "Emperatriz Ortega",
        "Katia Roque",
        "Tatiana Vidaurre",
        "Sophia Lozano",
        "Shirley Quintana",
        "Jule Vasquez",
        "Lourdes Lopez",
        "Cindy Alcarraz",
        "Alonso Diaz",
        "Claudio Flores",
        "Cesar Samanez-Figari"
    ],
    "author_dict_list": [
        {
            "author_name": "Daniel J Enriquez",
            "author_affiliations": [
                "Universidad Privada San Juan Bautista, Lima, Peru"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Jhoisy Casas",
            "author_affiliations": [
                "Universidad Nacional Federico Villareal, Lima, Peru"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gustavo Sandival",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Johan Espino",
            "author_affiliations": [
                "Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Evelyn Espinoza-Morales",
            "author_affiliations": [
                "Escuela Profesional de Medicina Humana, Universidad Privada San Juan Bautista., Lima, Peru"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elizabeth Cervantes",
            "author_affiliations": [
                "Servicio de Citometr\u00eda de Flujo, Instituto Nacional de Enfermedades Neoplasicas, surquillo, Peru"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Melanie Castro-Mollo",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "F\u00e1tima Jim\u00e9nez-Mozo",
            "author_affiliations": [
                "Universidad Nacional Federico Villarreal, Lima, Peru"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Daniela Due\u00f1as",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlos Barrionuevo",
            "author_affiliations": [
                "Department of Pathology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Juan C Haro",
            "author_affiliations": [
                "Medical Oncology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emperatriz Ortega",
            "author_affiliations": [
                "Medical Oncology, Instituto nacional de Enfermedades neoplasica, Lima, Peru"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Katia Roque",
            "author_affiliations": [
                "Medical Oncology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Tatiana Vidaurre",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neopl\u00e1sicas, Lima, Peru"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sophia Lozano",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neopl\u00e1sicas, Lima, Peru"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Shirley Quintana",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jule Vasquez",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neopl\u00e1sicas, Lima, Peru"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lourdes Lopez",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cindy Alcarraz",
            "author_affiliations": [
                "Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru",
                "Oncosalud - AUNA, Lima, Peru"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alonso Diaz",
            "author_affiliations": [
                "Oncosalud - AUNA, Lima, Peru"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Claudio Flores",
            "author_affiliations": [
                "Oncosalud - AUNA, Lima, Peru"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Cesar Samanez-Figari",
            "author_affiliations": [
                "Oncosalud - AUNA, Lima, Peru"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-23T04:02:15",
    "is_scraped": "1"
}